These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Newly developed H2-receptor antagonists in the treatment of peptic ulcer disease].
    Author: Simon B, Müller P, Dammann HG.
    Journal: Wien Med Wochenschr; 1982 May 31; 132(10):223-8. PubMed ID: 6126962.
    Abstract:
    Ranitidine and oxmetidine are newly developed histamine H2-receptor antagonists without any antiandrogenic activity and probably without drug interactions. In numerous clinical trials ranitidine has been proven to be at least as effective as cimetidine in the short- and long-term treatment of peptic ulcer disease. Ranitidine was found to be remarkably safe. Its therapeutic use in man should not be associated with significant adverse reactions.
    [Abstract] [Full Text] [Related] [New Search]